Abbott Laboratories

Abbott Laboratories is a global healthcare company dedicated to helping people live fuller, healthier lives through the power of health. The company's mission involves bringing new products and technologies to the world across nutrition, diagnostics, medical devices, and branded generic pharmaceuticals. Headquartered in Abbott Park, Illinois, U.S., Abbott operates worldwide, serving over 160 countries.

Abbott's operations are structured into four primary segments: Medical Devices, Diagnostics, Nutritional Products, and Established Pharmaceuticals. Its diverse portfolio includes leading products such as the FreeStyle Libre system for continuous glucose monitoring, popular nutritional brands like Ensure and Similac, and a wide array of cardiovascular and neuromodulation devices. The company's offerings cater to various market segments, including patients managing chronic conditions, individuals seeking wellness optimization, and healthcare providers.

Under the leadership of Chairman and CEO Robert B. Ford, Abbott maintains a strong market position driven by its diversified business model, continuous innovation, and extensive global presence. Recent strategic initiatives include the ongoing expansion of its FreeStyle Libre system and the planned acquisition of Exact Sciences Corporation, aimed at strengthening its foothold in the cancer diagnostics market. Abbott reported full-year 2025 sales of $44.3 billion and anticipates organic sales growth in 2026, underscoring its robust market positioning.